These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Utilization of erythropoietin in the treatment of the anemia due to chronic renal failure.
    Author: Drüeke T, Zins B, Naret C, Casadevall N, Goureau Y, Bererhi L, Peterlongo F, Castaigne JP, Zingraff J, Delons S.
    Journal: Adv Nephrol Necker Hosp; 1989; 18():187-206. PubMed ID: 2493715.
    Abstract:
    Administration of recombinant erythropoietin constitutes a revolution in treatment of the anemia of chronic dialysis patients. Such treatment has been anxiously awaited. Its realization has been possible thanks to the spectacular progress allowed by the newly developed techniques of recombinant genetics. Correction of this type of anemia can be obtained rapidly and permanently if treatment is continued without interruption. It is followed by a remarkable transformation of the patient's physical and psychic status. The occurrence of certain side effects (e.g., elevation of blood pressure and an increased tendency toward vascular thrombosis), however, requires increased awareness in the follow-up of patients at risk and adaptation of erythropoietin administration to individual needs.
    [Abstract] [Full Text] [Related] [New Search]